Alpha-1-antitrypsine dephiciency. Can we improve prognosis?

A. Escribano, O. Gómez, P. Codoñer, M. Tortajada, N. Díez (Valencia, Spain)

Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Session: Pulmonary infections in children - rare but important aspects
Session type: Oral Presentation
Number: 2767
Disease area: Paediatric lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Escribano, O. Gómez, P. Codoñer, M. Tortajada, N. Díez (Valencia, Spain). Alpha-1-antitrypsine dephiciency. Can we improve prognosis?. Eur Respir J 2008; 32: Suppl. 52, 2767

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How to improve compliance with CPAP/NIV?
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017

How exactly can we predict the prognosis of COPD?
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006

Physicians or prediction rules; who is better at predicting prognosis?
Source: Eur Respir J 2007; 30: Suppl. 51, 124s
Year: 2007

Poor performance status patient in advanced lung cancer: to treat or not to treat?
Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat?
Year: 2008

How can we improve the management and outcome of pneumonia in the elderly?
Source: Eur Respir J 2008; 32: 12-14
Year: 2008


COPD: implementing biomarkers to improve prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021


Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 281-282
Year: 2016


Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 279-281
Year: 2016


How can real-world data be used to improve outcomes?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021



Early bedside clinical prediction of deterioration in COVID-19 happy hypoxaemic phenotype associated with good prognosis.
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Can nutrition improve performance in COPD?
Source: International Congress 2015 – Nutrition in chronic respiratory disease
Year: 2015



To achieve only primary education is associated with COPD and poor prognosis
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Which tools to improve early diagnosis of COPD in primary care?
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009


Does the endotype-driven approach translate into improved quality of life?
Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action
Year: 2020

How do differences in the definition of good quality care affect classification of hospital performance?
Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care
Year: 2020




How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


Long-term management, functional outcome and results
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=179
Year: 2003

Patient-reported outcome measures: do they improve the quality of supportive care in advanced non-small cell lung cancer?
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021